Skip to Content

DROXIA 6336 DROXIA 6336 (Droxia 300 mg)

Generic Name: hydroxyurea

Pill with imprint DROXIA 6336 DROXIA 6336 is Purple, Capsule-shape and has been identified as Droxia 300 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DROXIA 6336 DROXIA 6336

Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336

Droxia

Generic Name:
hydroxyurea
Imprint:
DROXIA 6336 DROXIA 6336
Strength:
300 mg
Color:
Purple
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide